Bernd Jilma
Researcher Next ID · RN-039924
Researcher · Medicine
Accent Therapeutics (United States)
Lexington, Austria
- Works count
- 779
- Citation count
- 24,494
- H-index
- 74
- i10-index
- 434
Research interests
Publications
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis
Research and Practice in Thrombosis and Haemostasis · 2020 · https://doi.org/10.1002/rth2.12439
Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells
Circulation Research · 2019 · https://doi.org/10.1161/circresaha.118.314601
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
Leukemia · 2017 · https://doi.org/10.1038/leu.2017.245
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1505533
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial
European Heart Journal · 2015 · https://doi.org/10.1093/eurheartj/ehv547
Heparin Blunts Endotoxin-Induced Coagulation Activation
Circulation · 1999 · https://doi.org/10.1161/01.cir.100.25.2485
Current projects
No projects listed.